Head-to-head · free

Sabra Healthcare REIT vs Charles Schwab

SBRA vs SCHW — return on capital, cash generation, margins and balance sheet side by side.

SBRA

1 / 4

measures where SBRA leads

SCHW

3 / 4

measures where SCHW leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureSBRA · FY2025SCHW · FY2025
Revenue$774.6M$23.9B
Net income$155.6M$8.9B
Revenue growth (yearly, multi-year)8.0%6.6%
Free cash flow—$8.8B
Free cash flow margin—36.6%
Net cash / (debt)——
ROIC4.8%—
Return on equity5.6%20.6%
Gross margin65.0%—
Operating margin34.1%—
Net debt / EBITDA5.55x—

Figures are as reported by each company; latest fiscal year shown.

Where Sabra Healthcare REIT's cash went (FY2025)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full SBRA profile →

Where Charles Schwab's cash went (FY2025)

Capital spending
$548.0M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full SCHW profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons